↓ Skip to main content

Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: Safety, tolerability, and efficacy

Overview of attention for article published in Drug, Healthcare and Patient Safety, September 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#35 of 160)
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
6 patents

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: Safety, tolerability, and efficacy
Published in
Drug, Healthcare and Patient Safety, September 2010
DOI 10.2147/dhps.s6215
Pubmed ID
Authors

Jeremy Feldman, Mitchell Buckley, Laura Wicks, Robin Staib, Jeremy Feldman

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 45 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 24%
Researcher 10 22%
Student > Ph. D. Student 6 13%
Other 4 9%
Student > Postgraduate 3 7%
Other 5 11%
Unknown 7 15%
Readers by discipline Count As %
Medicine and Dentistry 13 28%
Pharmacology, Toxicology and Pharmaceutical Science 7 15%
Agricultural and Biological Sciences 4 9%
Biochemistry, Genetics and Molecular Biology 4 9%
Chemical Engineering 1 2%
Other 6 13%
Unknown 11 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2024.
All research outputs
#3,831,549
of 25,540,105 outputs
Outputs from Drug, Healthcare and Patient Safety
#35
of 160 outputs
Outputs of similar age
#14,892
of 104,170 outputs
Outputs of similar age from Drug, Healthcare and Patient Safety
#4
of 7 outputs
Altmetric has tracked 25,540,105 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 160 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,170 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.